Expression of the tyrosine kinase discoidin domain receptor 1 (DDR1) in human central nervous system myelin

Brain Research

Volumn 1336, Issue , 2010, Pages 22-29

  Roig, Bàrbara ^a   Franco Pons, Neus ^a   Martorell, Lourdes ^a   Tomàs, Jordi ^a   Vogel, Wolfgang F ^b   Vilella, Elisabet ^a  

^a IISPV   (Spain)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

DDR1; Human cerebral cortex; Myelin; Oligodendrocyte; Schizophrenia; White matter

Indexed keywords

DISCOIDIN DOMAIN RECEPTOR 1; MESSENGER RNA; MYELIN; MYELIN ASSOCIATED GLYCOPROTEIN; MYELIN BASIC PROTEIN; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASTROCYTE; CAPILLARY ENDOTHELIUM; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LOCALIZATION; GENE EXPRESSION; GENETIC ASSOCIATION; GRAY MATTER; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; MYELIN SHEATH; MYELINATION; NERVE CELL DIFFERENTIATION; NORMAL HUMAN; OCCIPITAL CORTEX; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; WHITE MATTER;

ASTROCYTES; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BLOTTING, WESTERN; CEREBRAL CORTEX; ENDOTHELIAL CELLS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MYELIN BASIC PROTEINS; MYELIN SHEATH; MYELIN-ASSOCIATED GLYCOPROTEIN; NERVE TISSUE PROTEINS; OLIGODENDROGLIA; RECEPTOR PROTEIN-TYROSINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

MUS;

EID: 77952239905     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.03.099     Document Type: Article

References (46)

1. Alves F., Vogel W., Mossie K., Millauer B., Hofler H., and Ullrich A. Distinct structural characteristics of discoidin I subfamily receptor tyrosine kinases and complementary expression in human cancer. Oncogene 10 (1995) 609-618
2. Bhat R.V., Axt K.J., Fosnaugh J.S., Smith K.J., Johnson K.A., Hill D.E., Kinzler K.W., and Baraban J.M. Expression of the APC tumor suppressor protein in oligodendroglia. Glia 17 (1996) 169-174
3. Bhatt R.S., Tomoda T., Fang Y., and Hatten M.E. Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons. Genes Dev. 14 (2000) 2216-2228
4. Blume-Jensen P., and Hunter T. Oncogenic kinase signalling. Nature 411 (2001) 355-365
5. Bustin S.A., Benes V., Garson J.A., Hellemans J., Huggett J., Kubista M., Mueller R., Nolan T., Pfaffl M.W., Shipley G.L., Vandesompele J., and Wittwer C. The MIQE Guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 55 (2009) 611-622
6. Chambers J.S., and Perrone-Bizzozero N.I. Altered myelination of the hippocampal formation in subjects with schizophrenia and bipolar disorder. Neurochem. Res. 29 (2004) 2293-2302
7. Chao M.V. Neurotrophin receptors: a window into neuronal differentiation. Neuron 9 (1992) 583-593
8. Curat C.A., and Vogel W.F. Discoidin domain receptor 1 controls growth and adhesion of mesangial cells. J. Am. Soc. Nephrol. 13 (2002) 2648-2656
9. Davis K.L., Stewart D.G., Friedman J.I., Buchsbaum M., Harvey P.D., Hof P.R., Buxbaum J., and Haroutunian V. White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch. Gen. Psychiatry 60 (2003) 443-456
10. Dwork A.J., Mancevski B., and Rosoklija G. White matter and cognitive function in schizophrenia. Int. J. Neuropsychopharmacol. 10 (2007) 513-536
11. Ferrer I., Pastor P., Rey M.J., Munoz E., Puig B., Pastor E., Oliva R., and Tolosa E. Tau phosphorylation and kinase activation in familial tauopathy linked to deln296 mutation. Neuropathol. Appl. Neurobiol. 29 (2003) 23-34
12. Ferri N., Carragher N.O., and Raines E.W. Role of discoidin domain receptors 1 and 2 in human smooth muscle cell-mediated collagen remodeling: potential implications in atherosclerosis and lymphangioleiomyomatosis. Am. J. Pathol. 164 (2004) 1575-1585
13. Flynn L.A., Blisset A.R., Calomeni E.P., and Agarwal G. Inhibition of collagen fibrillogenesis soluble extracellular domains of DDR1 and DDR2. J. Mol. Biol. (2009) 10.1016/j.jmb.2009.10.073
14. Franco C., Hou G., Ahmad P.J., Fu E.Y., Koh L., Vogel W.F., and Bendeck M.P. Discoidin domain receptor 1 (ddr1) deletion decreases atherosclerosis by accelerating matrix accumulation and reducing inflammation in low-density lipoprotein receptor-deficient mice. Circ. Res. 102 (2008) 1202-1211
15. Franco-Pons N., Virgos C., Vogel W.F., Urena J.M., Soriano E., Del Rio J.A., and Vilella E. Expression of discoidin domain receptor 1 during mouse brain development follows the progress of myelination. Neuroscience 140 (2006) 463-475
16. Franco-Pons N., Tomas J., Roig B., Auladell C., Martorell L., and Vilella E. Discoidin domain receptor 1, a tyrosine kinase receptor, is upregulated in an experimental model of remyelination and during oligodendrocyte differentiation in vitro. J. Mol. Neurosci. 38 (2009) 2-11
17. Georgieva L., Moskvina V., Peirce T., Norton N., Bray N.J., Jones L., Holmans P., Macgregor S., Zammit S., Wilkinson J., Williams H., Nikolov I., Williams N., Ivanov D., Davis K.L., Haroutunian V., Buxbaum J.D., Craddock N., Kirov G., Owen M.J., and O'Donovan M.C. Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 12469-12474
18. Hou G., Vogel W., and Bendeck M.P. The discoidin domain receptor tyrosine kinase DDR1 in arterial wound repair. J. Clin. Invest. 107 (2001) 727-735
19. Hruban R.H., Kuhajda F.P., and Mann R.B. Acute myelofibrosis. immunohistochemical study of four cases and comparison with acute megakaryocytic leukemia. Am. J. Clin. Pathol. 88 (1987) 578-588
20. Huang Y., Arora P., McCulloch C.A., and Vogel W.F. The collagen receptor DDR1 regulates cell spreading and motility by associating with myosin IIA. J. Cell Sci. 122 (2009) 1637-1646
21. Ligon K.L., Fancy S.P., Franklin R.J., and Rowitch D.H. Olig gene function in CNS development and disease. Glia 54 (2006) 1-10
22. Matsuyama W., Wang L., Farrar W.L., Faure M., and Yoshimura T. Activation of discoidin domain receptor 1 isoform b with collagen up-regulates chemokine production in human macrophages: role of p38 mitogen-activated protein kinase and NF-kappa B. J. Immunol. 172 (2004) 2332-2340
23. Matthieu J.M. Myelin basic protein and the stability of the multilamellar myelin structure. Bull. Schweiz. Akad. Med. Wiss. (1981) 101-108
24. Meyer zum Gottesberge A.M., Gross O., Becker-Lendzian U., Massing T., and Vogel W.F. Inner ear defects and hearing loss in mice lacking the collagen receptor DDR1. Lab. Invest. 88 (2008) 27-37
25. Mohan R.R., Mohan R.R., and Wilson S.E. Discoidin domain receptor (DDR) 1 and 2: collagen-activated tyrosine kinase receptors in the cornea. Exp. Eye Res. 72 (2001) 87-92
26. Peirce T.R., Bray N.J., Williams N.M., Norton N., Moskvina V., Preece A., Haroutunian V., Buxbaum J.D., Owen M.J., and O'Donovan M.C. Convergent evidence for 2', 3'-cyclic nucleotide 3'-phosphodiesterase as a possible susceptibility gene for schizophrenia. Arch. Gen. Psychiatry 63 (2006) 18-24
27. Roig B., Virgos C., Franco N., Martorell L., Valero J., Costas J., Carracedo A., Labad A., and Vilella E. The discoidin domain receptor 1 as a novel susceptibility gene for schizophrenia. Mol. Psychiatry 12 (2007) 833-841
28. Sakamoto O., Suga M., Suda T., and Ando M. Expression of discoidin domain receptor 1 tyrosine kinase on the human bronchial epithelium. Eur. Respir. J. 17 (2001) 969-974
29. Sakuma S., Saya H., Tada M., Nakao M., Fujiwara T., Roth J.A., Sawamura Y., Shinohe Y., and Abe H. Receptor protein tyrosine kinase DDR is up-regulated by p53 protein. FEBS Lett. 398 (1996) 165-169
30. Sanchez M.P., Tapley P., Saini S.S., He B., Pulido D., and Barbacid M. Multiple tyrosine protein kinases in rat hippocampal neurons: isolation of ptk-3, a receptor expressed in proliferative zones of the developing brain. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 1819-1823
31. Schachner M., and Bartsch U. Multiple functions of the myelin-associated glycoprotein MAG (siglec-4a) in formation and maintenance of myelin. Glia 29 (2000) 154-165
32. Seo M.C., Kim S., Kim S.H., Zheng L.T., Park E.K., Lee W.H., and Suk K. Discoidin domain receptor 1 mediates collagen-induced inflammatory activation of microglia in culture. J. Neurosci. Res. 86 (2008) 1087-1095
33. Shintani Y., Fukumoto Y., Chaika N., Svoboda R., Wheelock M.J., and Johnson K.R. Collagen I-mediated up-regulation of N-cadherin requires cooperative signals from integrins and discoidin domain receptor 1. J. Cell Biol. 180 (2008) 1277-1289
34. Slack B.E., Siniaia M.S., and Blusztajn J.K. Collagen type I selectively activates ectodomain shedding of the discoidin domain receptor 1: involvement of src tyrosine kinase. J. Cell Biochem. 98 (2006) 672-684
35. Song J., Goetz B.D., Baas P.W., and Duncan I.D. Cytoskeletal reorganization during the formation of oligodendrocyte processes and branches. Mol.Cell. Neurosci. 17 (2001) 624-636
36. Tanaka K., Nagayama Y., Nakano T., Takamura N., Namba H., Fukada S., Kuma K., Yamashita S., and Niwa M. Expression profile of receptor-type protein tyrosine kinase genes in the human thyroid. Endocrinology 139 (1998) 852-858
37. Torrey E.F., Webster M., Knable M., Johnston N., and Yolken R.H. The stanley foundation brain collection and neuropathology consortium. Schizophr. Res. 44 (2000) 151-155
38. Vogel W.F. Ligand-induced shedding of discoidin domain receptor 1. FEBS Lett. 514 (2002) 175-180
39. Vogel W., Gish G.D., Alves F., and Pawson T. The discoidin domain receptor tyrosine kinases are activated by collagen. Mol. Cell 1 (1997) 13-23
40. Vogel W.F., Abdulhussein R., and Ford C.E. Sensing extracellular matrix: an update on discoidin domain receptor function. Cell Signal. 18 (2006) 1108-1116
41. Walterfang M., Wood S.J., Velakoulis D., and Pantelis C. Neuropathological, neurogenetic and neuroimaging evidence for white matter pathology in schizophrenia. Neurosci. Biobehav. Rev. 30 (2006) 918-948
42. Weiner H.L., Huang H., Zagzag D., Boyce H., Lichtenbaum R., and Ziff E.B. Consistent and selective expression of the discoidin domain receptor-1 tyrosine kinase in human brain tumors. Neurosurgery 47 (2000) 1400-1409
43. Yamanaka R., Arao T., Yajima N., Tsuchiya N., Homma J., Tanaka R., Sano M., Oide A., Sekijima M., and Nishio K. Identification of expressed genes characterizing long-term survival in malignant glioma patients. Oncogene 44 (2006) 5994-6002
44. Yeh Y.C., Wang C.Z., and Tang M.J. Discoidin domain receptor 1 activation suppresses alpha2beta1 integrin-dependent cell spreading through inhibition of Cdc42 activity. J. Cell Physiol. 218 (2009) 146-156
45. Yool D., Montague P., McLaughlin M., McCulloch M.C., Edgar J.M., Nave K.A., Davies R.W., Griffiths I.R., and McCallion A.S. Phenotypic analysis of mice deficient in the major myelin protein MOBP, and evidence for a novel mobp isoform. Glia 39 (2002) 256-267
46. Zerlin M., Julius M.A., and Goldfarb M. NEP: a novel receptor-like tyrosine kinase expressed in proliferating neuroepithelia. Oncogene 8 (1993) 2731-2739